Design, Setting and Participants
Main Outcome Measures
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Risk of non-fatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 ��g of ethinyl estradiol.Contraception. 2006; 73: 223-228
- Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.Obstet Gynecol. 2007; 109: 339-346